Skip to main content
Fig. 1 | Health and Quality of Life Outcomes

Fig. 1

From: Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire

Fig. 1

Physical impact of PsA. a Patient-reported musculoskeletal symptoms related to PsA experienced in the past 12 months; b Patient-reported moderate/major physical impact of PsA. Data represent the percentage of responders using the weighted base of each country in Table 1. a Data are reported in response to the question, “Which of the following symptoms, if any, have you experienced in the past 12 months related to psoriatic arthritis? Please select all that apply.” b Data are reported in response to the question, “How much of a negative impact, if any, has psoriatic arthritis had on each of the following aspects of your life (no impact/slight/moderate/major)?” Data represent sum of moderate/major impact, and countries are represented by colored data bars. Significant differences (p < 0.05) between countries are designated by the letters following the bars: a = Australia; b = Brazil; c = Canada; d = France; e = Spain; f = Taiwan; g = UK; h = US. PsA, psoriatic arthritis.

Back to article page